BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kimura W, Tezuka K, Hirai I. Surgical management of pancreatic neuroendocrine tumors. Surg Today. 2011;41:1332-1343. [PMID: 21922354 DOI: 10.1007/s00595-011-4547-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.4] [Reference Citation Analysis]
Number Citing Articles
1 Hori T, Takaori K, Uemoto S. Pancreatic neuroendocrine tumor accompanied with multiple liver metastases. World J Hepatol 2014; 6(8): 596-600 [PMID: 25232452 DOI: 10.4254/wjh.v6.i8.596] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
2 Engler CC, Lemke J, Kornmann M, Barth TF, Schmidt SA, Henne-Bruns D. Ectopic spleen and liver hemangioma mimicking metastatic pancreatic neuroendocrine tumor. Int J Surg Case Rep. 2015;17:139-142. [PMID: 26670205 DOI: 10.1016/j.ijscr.2015.10.041] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
3 Ter-Minassian M, Chan JA, Hooshmand SM, Brais LK, Daskalova A, Heafield R, Buchanan L, Qian ZR, Fuchs CS, Lin X. Clinical presentation, recurrence, and survival in patients with neuroendocrine tumors: results from a prospective institutional database. Endocr Relat Cancer. 2013;20:187-196. [PMID: 23319495 DOI: 10.1530/erc-12-0340] [Cited by in Crossref: 65] [Cited by in F6Publishing: 35] [Article Influence: 8.1] [Reference Citation Analysis]
4 Rossi S, Viera FT, Ghittoni G, Cobianchi L, Rosa LL, Siciliani L, Bortolotto C, Veronese L, Vercelli A, Gallotti A, Ravetta V. Radiofrequency ablation of pancreatic neuroendocrine tumors: a pilot study of feasibility, efficacy, and safety. Pancreas. 2014;43:938-945. [PMID: 24717825 DOI: 10.1097/mpa.0000000000000133] [Cited by in Crossref: 52] [Cited by in F6Publishing: 28] [Article Influence: 8.7] [Reference Citation Analysis]
5 Iacobone M, Citton M, Nitti D. Laparoscopic distal pancreatectomy: Up-to-date and literature review. World J Gastroenterol 2012; 18(38): 5329-5337 [PMID: 23082049 DOI: 10.3748/wjg.v18.i38.5329] [Cited by in CrossRef: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
6 Kauffmann EF, Napoli N, Genovese V, Ginesini M, Gianfaldoni C, Vistoli F, Amorese G, Boggi U. Feasibility and safety of robotic-assisted total pancreatectomy: a pilot western series. Updates Surg 2021;73:955-66. [PMID: 34009627 DOI: 10.1007/s13304-021-01079-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Cao X, Wang X, Lu Y, Zhao B, Shi J, Guan Q, Zhang X. Spleen-preserving distal pancreatectomy and lymphadenectomy for glucagonoma syndrome: A case report. Medicine (Baltimore) 2019;98:e17037. [PMID: 31567941 DOI: 10.1097/MD.0000000000017037] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Habbe N, Fendrich V, Heverhagen A, Ramaswamy A, Bartsch DK. Outcome of surgery for ileojejunal neuroendocrine tumors. Surg Today 2013;43:1168-74. [PMID: 23143168 DOI: 10.1007/s00595-012-0408-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
9 Ji R, Zuo S, Qiu S, Li P, Chan A, Sharr W, Lo CM. Combined associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) followed by left trisectionectomy and Whipple operation for PNET. Gland Surg 2018;7:47-53. [PMID: 29629320 DOI: 10.21037/gs.2017.11.15] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
10 Sadaria MR, Hruban RH, Edil BH. Advancements in pancreatic neuroendocrine tumors. Expert Rev Gastroenterol Hepatol. 2013;7:477-490. [PMID: 23899286 DOI: 10.1586/17474124.2013.811058] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
11 Lopez-Aguiar AG, Ethun CG, Postlewait LM, Zhelnin K, Krasinskas A, El-Rayes BF, Russell MC, Sarmiento JM, Kooby DA, Staley CA, Maithel SK, Cardona K. Redefining the Ki-67 Index Stratification for Low-Grade Pancreatic Neuroendocrine Tumors: Improving Its Prognostic Value for Recurrence of Disease. Ann Surg Oncol 2018;25:290-8. [PMID: 29079920 DOI: 10.1245/s10434-017-6140-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
12 Miki M, Ito T, Hijioka M, Lee L, Yasunaga K, Ueda K, Fujiyama T, Tachibana Y, Kawabe K, Jensen RT, Ogawa Y. Utility of chromogranin B compared with chromogranin A as a biomarker in Japanese patients with pancreatic neuroendocrine tumors. Jpn J Clin Oncol 2017;47:520-8. [PMID: 28334992 DOI: 10.1093/jjco/hyx032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
13 Lee E, Leon Pachter H, Sarpel U. Hepatic arterial embolization for the treatment of metastatic neuroendocrine tumors. Int J Hepatol. 2012;2012:471203. [PMID: 22319651 DOI: 10.1155/2012/471203] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
14 McKenna LR, Edil BH. Update on pancreatic neuroendocrine tumors. Gland Surg. 2014;3:258-275. [PMID: 25493258 DOI: 10.3978/j.issn.2227-684x.2014.06.03] [Cited by in F6Publishing: 25] [Reference Citation Analysis]
15 Hanazaki K, Sakurai A, Munekage M, Ichikawa K, Namikawa T, Okabayashi T, Imamura M. Surgery for a gastroenteropancreatic neuroendocrine tumor (GEPNET) in multiple endocrine neoplasia type 1. Surg Today. 2013;43:229-236. [PMID: 23076685 DOI: 10.1007/s00595-012-0376-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
16 Ozkan E, Soydal C, Ucak Semirgin S, Yapici O, Atmaca A, Demirag G. Early Response to Everolimus Therapy Detected on 68Ga-DOTATATE PET/CT in a Patient With Pancreatic Neuroendocrine Tumor. Clinical Nuclear Medicine 2016;41:561-3. [DOI: 10.1097/rlu.0000000000001242] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
17 Cienfuegos JA, Salguero J, Núñez-córdoba JM, Ruiz-canela M, Benito A, Ocaña S, Zozaya G, Martí-cruchaga P, Pardo F, Hernández-lizoáin JL, Rotellar F. Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience. Surg Endosc 2017;31:3847-57. [DOI: 10.1007/s00464-016-5411-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
18 Shrikhande SV, Sirohi B, Goel M, Barreto SG. Pancreatic neuroendocrine tumors. Indian J Gastroenterol 2013;32:3-17. [PMID: 23054950 DOI: 10.1007/s12664-012-0257-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
19 Rodriguez RA, Overton H, Morris KT. Pancreatic neuroendocrine tumor with splenic vein tumor thrombus: A case report. Int J Surg Case Rep 2014;5:1271-4. [PMID: 25460491 DOI: 10.1016/j.ijscr.2014.11.045] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
20 Kumar S, Raobiakady R, Watkins D, Terlizzo M, Bhogal RH. Radical resection of large metastatic non-functioning pancreatic neuroendocrine carcinoma complicated by splenic vein thrombosis and sinistral portal hypertension. Int J Surg Case Rep 2021;81:105724. [PMID: 33820735 DOI: 10.1016/j.ijscr.2021.105724] [Reference Citation Analysis]
21 Olstad KJ, Kasantikul T, Kiupel M, Reader JR. Mixed Malignant Pancreatic Tumour in a Rhesus Macaque (Macaca mullata). J Comp Pathol 2019;167:46-9. [PMID: 30898297 DOI: 10.1016/j.jcpa.2018.12.003] [Reference Citation Analysis]
22 Tezuka K, Kimura W, Hirai I, Moriya T, Watanabe T, Yano M. Postoperative Hematological Changes after Spleen-Preserving Distal Pancreatectomy with Preservation of the Splenic Artery and Vein. Dig Surg 2012;29:157-64. [DOI: 10.1159/000337312] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
23 Orditura M, Petrillo A, Ventriglia J, Diana A, Laterza MM, Fabozzi A, Savastano B, Franzese E, Conzo G, Santini L, Ciardiello F, De Vita F. Pancreatic neuroendocrine tumors: Nosography, management and treatment. Int J Surg. 2016;28 Suppl 1:S156-S162. [PMID: 26708853 DOI: 10.1016/j.ijsu.2015.12.052] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 3.8] [Reference Citation Analysis]